Showing all 8 results
Aceclofenac Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Standard) or Sustained Release (SR) Tablets.
Active Ingredient Strength Release Type Role Aceclofenac IP/BP/USP 100 mg Immediate Release Standard Adult Dose Aceclofenac IP/BP/USP 200 mg Sustained Release (SR) Once Daily Dosing Excipients Q.S. — Disintegrant / Binder Codeine Phosphate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Narcotic Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the alkaloid salt and to strictly prevent diversion.
Active Ingredient Strength Primary Clinical Function Codeine Phosphate USP/Ph.Eur. 15 mg / 30 mg The Standard Analgesic / Antitussive Anchor: The definitive unit utilized for the suppression of severe, dry coughs and the management of mild-to-moderate acute somatic pain. Codeine Phosphate USP/Ph.Eur. 60 mg The Severe Trauma Macrodose: The heavy therapeutic payload utilized strictly for moderate-to-severe refractory pain, often in post-operative or palliative oncology settings. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Magnesium Stearate / Colloidal Silicon Dioxide Diluent / Densifier / Superdisintegrant / Lubricant / Glidant (Engineered utilizing Strict Geometric Dilution to ensure the opiate payload is flawlessly uniform across every batch, preventing toxic “hot spots” that could trigger accidental respiratory depression) *Pack Sizes: 10×10 Tamper-Evident Blisters (Optimized specifically for strict, closely monitored acute pain dispensing regimens).
Diclofenac Potassium Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets (Red/Brown) or Film Coated Tablets. Sugar coating is traditional to effectively mask the bitter taste of the API.
Active Ingredient Strength (Standard) Primary Indication Diclofenac Potassium USP/BP 25 mg Pediatric (Older) / Mild Pain Diclofenac Potassium USP/BP 50 mg Standard Adult Acute Dose Diclofenac Potassium USP/BP 75 mg Severe Acute Pain (Post-Op) Excipients Q.S. Sucrose (Coating) / Maize Starch Diclofenac Tablets
FreeProduct Composition & Strength
We supply this product as Enteric Coated (Gastro-Resistant) Tablets or Sustained Release (SR) Tablets.
Active Ingredient Strength (Standard) Formulation Role Diclofenac Sodium USP/BP 25 mg Enteric Coated Pediatric / Mild Pain Diclofenac Sodium USP/BP 50 mg Enteric Coated Standard Acute Dose Diclofenac Sodium USP/BP 75 mg Enteric Coated / SR Intermediate / Injection Switch Diclofenac Sodium USP/BP 100 mg Sustained Release (SR) Once Daily (Chronic Pain) Etoricoxib Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (distinctively colored by strength). The coating masks the bitter taste and ensures stability.
Active Ingredient Strength (Standard) Color (Typical) Primary Indication Etoricoxib USP/BP 60 mg Green Osteoarthritis / Chronic Pain Etoricoxib USP/BP 90 mg White Rheumatoid Arthritis / Dental Pain Etoricoxib USP/BP 120 mg Pale Green Acute Gout (Short Term) Mefanamic Acid & Dicyclomine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant PVC/PVDC or Alu-Alu blister strips to ensure the absolute chemical stability of the combined APIs.
Active Ingredient Strength Primary Clinical Function Mefenamic Acid USP/Ph.Eur. 250 mg The Anti-Inflammatory Anchor: Rapidly reduces prostaglandin-induced pain, uterine inflammation, and heavy menstrual bleeding. Dicyclomine Hydrochloride USP/Ph.Eur. 10 mg The Antispasmodic Catalyst: Instantly relaxes violently contracting smooth muscle in the gastrointestinal and biliary tracts, and the uterus. Excipients Microcrystalline Cellulose / Maize Starch / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Binder / Superdisintegrant / Glidant (Engineered specifically to ensure the bulky Mefenamic Acid powder shatters and dissolves instantly upon reaching the gastric fluid, ensuring the 30-minute rapid onset required for acute pain rescue) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-volume, over-the-counter (OTC) or acute prescription dispensing regimens).
Morphine Sulphate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release Matrix Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Morphine Sulphate USP/Ph.Eur. 15 mg (SR) Initiation / Titration Standard: Base therapeutic unit for opioid-naïve patients starting around-the-clock chronic pain management. Morphine Sulphate USP/Ph.Eur. 30 mg / 60 mg (SR) Global Oncology Standard: High-dose adult maintenance therapy for severe, opioid-tolerant terminal cancer and intractable neuropathic pain. Excipients Hypromellose (HPMC) / Cetostearyl Alcohol / Lactose Monohydrate / Magnesium Stearate / Premium Color-Coded Film Hydrophilic Polymer / Lipophilic Retardant / Diluent / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the narcotic over 12 hours) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic oncology dispensing regimens; frequently color-coded by strength to prevent fatal dispensing errors).
Piroxicam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet or Hard Gelatin Capsule, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly insoluble active ingredient.
Active Ingredient Strength Primary Clinical Function Piroxicam USP/Ph.Eur. 10 mg Initiation / Elderly Standard: Reduced dose for elderly patients or those with mild renal impairment to mitigate gastrointestinal risks. Piroxicam USP/Ph.Eur. 20 mg Global Clinical Standard: Maximum adult daily dose for the once-daily, continuous suppression of severe rheumatoid and osteoarthritis. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Sodium Lauryl Sulfate / Magnesium Stearate Diluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically with high-grade surfactants to force the rapid gastric dissolution of the highly water-insoluble Piroxicam API) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic rheumatology and orthopedic dispensing regimens).
